PD 161570
192705-80-9CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1MKVMEJKNLUWFSQ-UHFFFAOYSA-Nstructure in first source
192705-80-9DTXSID80416145CHEMBL45827化学的特性Off-White Solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H301 (97.4%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
用途選択的 FGFR 阻害剤です(IC50 = 40 nM(FGFR),262 nM(PDGFR),3,700 nM(EGFR))。
用途選択的 FGFR 阻害剤です(IC50 = 40 nmol/l(FGFR),262 nmol/l(PDGFR),3,700 nmol/l (EGFR))。
使用A novel FGF-1 receptor tyrosine kinase inhibitor which has been shown to effectively suppress constitutive phosphorylation of the FGF-1 receptor in human ovarian carcinoma cells.
読み込み中…